» Articles » PMID: 28430913

Prediction of Adverse Events After Catheter-based Procedures in Adolescents and Adults with Congenital Heart Disease in the IMPACT Registry

Overview
Journal Eur Heart J
Date 2017 Apr 22
PMID 28430913
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: We sought to identify factors associated with major adverse events (MAE) after cardiac catheterization in adolescents and adults with congenital heart disease (CHD), and create the first model to individualize risk discussions in this growing population.

Methods And Results: Improving Pediatric and Adult Congenital Treatment (IMPACT), a National Cardiovascular Data Registry, contains congenital catheterization data from over 87 hospitals in the United States. Demographics, pre-procedure, and procedural variables were collected for patients over age 10. Multivariable logistic regression was used to identify significant predictors of MAE, a composite of death, urgent surgery or procedure due to a catheterization complication, transfusion, embolic stroke, tamponade, extracorporeal membrane oxygenation or ventricular assist device placement, and device embolization, malposition or thrombosis requiring surgical intervention. A risk score was built based on the effect sizes of each predictor and validated in a split sample. A MAE occurred in 686 (2.5%) of the 27 293 index procedures meeting inclusion criteria. The independent multivariate predictors of MAE were older age, pre-procedural anticoagulation use, renal disease, lower haemoglobin, lower oxygen saturation, non-elective procedure, higher index procedure risk and having had no prior cardiac procedures. Being underweight or overweight had borderline significance and was added to the model. The C-statistic for the model was robust at 0.787 in the derivation and 0.773 in the validation cohort.

Conclusion: The factors predicting adverse events after cardiac catheterization in adolescents and adults with CHD are different than in the general population. Validation of this model in other national or multi-institutional datasets is the next step.

Citing Articles

Using Quality Improvement to Optimize Blood Product Utilization in a Pediatric Cardiac Catheterization Laboratory.

Trivedi M, Sheth S, Cooper F, Elhoff J, Rodrigues M, Stapleton G Pediatr Cardiol. 2024; .

PMID: 39432097 DOI: 10.1007/s00246-024-03682-8.


PICS/AEPC/APPCS/CSANZ/SCAI/SOLACI: Expert Consensus Statement on Cardiac Catheterization for Pediatric Patients and Adults With Congenital Heart Disease.

Holzer R, Bergersen L, Thomson J, Aboulhosn J, Aggarwal V, Akagi T J Soc Cardiovasc Angiogr Interv. 2024; 3(1):101181.

PMID: 39131968 PMC: 11307799. DOI: 10.1016/j.jscai.2023.101181.


Procedural Characteristics and Outcomes of Transcatheter Interventions for Aortic Coarctation: A Report From the IMPACT Registry.

Stefanescu Schmidt A, Armstrong A, Kennedy K, Inglessis-Azuaje I, Horlick E, Holzer R J Soc Cardiovasc Angiogr Interv. 2024; 1(5):100393.

PMID: 39131475 PMC: 11308018. DOI: 10.1016/j.jscai.2022.100393.


A Risk Prediction Model of Serious Adverse Events After Cardiac Catheterization for Chinese Adults Patients with Moderate and Severe Congenital Heart Disease.

Hu J, Zhang Y, Zhang W, Liu J, Peng P Rev Cardiovasc Med. 2024; 23(12):415.

PMID: 39076665 PMC: 11270449. DOI: 10.31083/j.rcm2312415.


Upper body peripherally inserted central catheter in pediatric single ventricle patients.

Kaipa S, Mastropietro C, Bhai H, Lutfi R, Friedman M, Yabrodi M World J Cardiol. 2020; 12(10):484-491.

PMID: 33173567 PMC: 7596420. DOI: 10.4330/wjc.v12.i10.484.


References
1.
Bergersen L, Gauvreau K, Marshall A, Kreutzer J, Beekman R, Hirsch R . Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv. 2011; 4(2):188-94. DOI: 10.1161/CIRCINTERVENTIONS.110.959262. View

2.
Mehta S, Frutkin A, Lindsey J, House J, Spertus J, Rao S . Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2009; 2(3):222-9. DOI: 10.1161/CIRCINTERVENTIONS.108.846741. View

3.
Piper W, Malenka D, Ryan Jr T, Shubrooks Jr S, OConnor G, Robb J . Predicting vascular complications in percutaneous coronary interventions. Am Heart J. 2003; 145(6):1022-9. DOI: 10.1016/S0002-8703(03)00079-6. View

4.
Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S . Adverse event rates in congenital cardiac catheterization - a multi-center experience. Catheter Cardiovasc Interv. 2009; 75(3):389-400. DOI: 10.1002/ccd.22266. View

5.
Vincent R, Moore J, Beekman R, Benson L, Bergersen L, Holzer R . Procedural characteristics and adverse events in diagnostic and interventional catheterisations in paediatric and adult CHD: initial report from the IMPACT Registry. Cardiol Young. 2015; 26(1):70-8. DOI: 10.1017/S1047951114002637. View